Please assess the completion status of the following clinical trial:

Trial Title: Effects of CLA Supplements on Body Weight and Fat Oxidation

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* BMI 25-29.9 kg/m2~* Absence of a weight change of greater than 3 kg in the previous 6 months~Exclusion Criteria:~* Presence of a physical limitation to walking exercise~* Current or recent (6 months) enrollment in a commercial or self-prescribed weight loss program~* A history of metabolic disease-ie. renal, endocrine, hepatic or gastrointestinal disease that would impact the outcome of the study~* A history of a psychiatric or eating disorders Ÿ Presence of metal implants that would interfere with body composition analysis~* Fasting plasma cholesterol \>300mg/dl or triglycerides above 500 mg/dl.~* Abnormal EKG

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 44 Years
- Healthy Volunteers: f

Study Arms:
- CLA treatment (Type: ACTIVE_COMPARATOR): The group randomized to Conjugated Linoleic Acid (CLA) treatment at 4 grams per day of 39% cis-9, trans-11 CLA; 39% trans-10, cis-12 CLA; and 22% safflower oil for 6 months
- Placebo (Type: PLACEBO_COMPARATOR): The group randomized to control received 4 g/d of safflower oil.

Based on this trial design, predict the completion outcome and termination type (if applicable).